As human articular cartilage has limited intrinsic healing capacity, focal articular cartilage defects of the knee do not heal independently and frequently predispose patients to early osteoarthritis, which can lead to persistent knee pain, functional disability, and reduced quality of life.[@bib1], [@bib2], [@bib3], [@bib4], [@bib5] Although multiple surgical options, such as arthroscopic debridement, chondroplasty, osteochondral autografts, and osteoarticular transfer systems, have been proposed as treatment modalities for articular cartilage defects of the knee, no individual technique is able to induce articular cartilage regeneration with both hyaline-like cartilage and seamless integration into the surrounding cartilage and underlying bone.[@bib3]^,^[@bib6]

Bone marrow stimulation techniques, such as microfracture, were first developed in the 1950s by Pridie and Steadman with the aim of inducing subchondral bone bleeding, thereby releasing multipotent mesenchymal stem cells and growth factors into the defect site, resulting in the formation of a clot and eventual repair of the cartilage defect with fibrous and hyaline-like cartilage.[@bib7], [@bib8], [@bib9], [@bib10] Particularly in comparison to other techniques such as osteochondral grafting or transfer systems, microfracture avoids donor site morbidity and the need for multiple surgeries.[@bib6]^,^[@bib11] However, although it provides robust clinical results for smaller defects at a lower cost compared with osteoarticular allografts or staged osteochondral transplantation, the microfracture technique is limited because the resulting clot tends to produce a mix of fibrous and hyaline-like cartilage, thus having a poorer capacity to withstand repetitive load bearing.[@bib5]^,^[@bib6]^,^[@bib9]^,^[@bib12]^,^[@bib13]

With the advent of cell-free biological scaffolds, autologous matrix-induced chondrogenesis (AMIC) has been introduced as an innovative, single-stage solution to improve the efficacy of microfracture.[@bib3]^,^[@bib5]^,^[@bib11]^,^[@bib12] Via placement of biological scaffolds composed of porcine collagen matrix, polyglycolic acid, or hyaluronic acid over the cartilage defect after microfracture, AMIC provides a mechanically stable structure for subchondral blood to soak into.[@bib4]^,^[@bib11]^,^[@bib14] The matrix thereby acts as a biocompatible, temporary scaffold that concentrates the mesenchymal stem cells and growth factors in place, thereby concentrating them only over the defect and not throughout the joint.[@bib4]^,^[@bib11]^,^[@bib14] However, placement of the scaffolds can be technically challenging, as the matrices become soft and adherent upon contact with fluid or blood, and visualization can be limited through an arthroscopic camera. Thus, authors often describe the need to extend the arthroscopic portals or perform a mini-arthrotomy to facilitate placement, which may increase wound-related complications and delay recovery.[@bib5]^,^[@bib15]

As the popularity of cell-free biological scaffolds and the AMIC technique grows, there is a need to assess the clinical efficacy of an all-arthroscopic AMIC technique in the treatment of focal articular cartilage defects of the knee. Currently, limited literature is available that examines the early and medium-term outcomes of focal cartilage injuries of the knee treated with microfracture in conjunction with a cell-free hyaluron-based scaffold. The purpose of this study was to determine the clinical efficacy of an all-arthroscopic approach to AMIC for patients with articular cartilage lesions of the knee joint.

Methods {#sec1}
=======

Patient Recruitment {#sec1.1}
-------------------

This study analyzed the prospectively collected data of all patients who underwent AMIC using a cell-free hyaluron-based scaffold at our institution between November 2013 and January 2018. Approval was granted by our tertiary center's institutional review board. The inclusion criteria were patients aged 18 to 65 years with symptomatic articular cartilage defects of the medial femoral condyle, lateral femoral condyle, or trochlea, identified as International Cartilage Repair Society (ICRS) grade III and higher on preoperative magnetic resonance imaging (MRI), \<20 mm in diameter, who underwent microfracture with a hyaluron-based cell-free scaffold, and had ≥2 years of follow-up data available. Patients who were \<18 or \>65 years old; had a known history of autoimmune or inflammatory arthritis, previous intraarticular fracture, previous total meniscectomy, or instability of the knee; who underwent concurrent ligament reconstruction; had defects \>20 mm in diameter; or had incomplete or insufficient follow-up data were excluded from the study. The study criteria are shown in [Table 1](#tbl1){ref-type="table"}.Table 1Study inclusion and exclusion criteria.Inclusion CriteriaExclusion CriteriaAge \>18 and \<65 yearsAge \<18 or \>65 yearsSymptomatic articular cartilage defect, ICRS grade III and above, and \<20 mm in diameterKnown history of autoimmune or inflammatory arthritis, diffuse osteoarthritis, instability of the knee, prior intraarticular fracture, previous total meniscectomy, articular cartilage defect \>20 mm in diameterTreated with microfracture with a hyaluron-based cell-free scaffoldUnderwent concurrent ligamentous reconstructionPreoperative MRI availableIncomplete imaging data\>2 years of follow-up data availableInsufficient or lost to follow-up[^1]

Data Collection {#sec1.2}
---------------

The medical records, radiographic imaging, and surgical reports of all patients who met the inclusion criteria were collected and reviewed by a sports medicine fellowship-trained orthopaedic surgeon. Clinical data collected included baseline demographics, including age, sex, ethnicity, weight, height, body mass index (BMI), the affected knee, and any concurrent injuries. Surgical reports were reviewed to confirm the procedure done and postoperative rehabilitation plan. Patients were assessed preoperatively, 6 months postoperatively, and 2 years postoperatively using the International Knee Documentation Committee (IKDC) questionnaire, a validated questionnaire that assesses patients on 3 domains, symptoms, sports activity, and knee function, to provide an overall knee function score.[@bib16]^,^[@bib17] Patients were also assessed for postoperative complications, defined as skin or knee infections, skin dehiscence, iatrogenic fracture, hemarthrosis, or persistent pain postoperatively. All pre- and postoperative clinical outcome evaluations were performed by trained physiotherapists at our orthopaedic diagnostic center, an independent unit that tracks clinical outcomes and postoperative functional assessments for our department's patients.

Preoperative MRIs and operative reports were reviewed to better characterize the articular cartilage lesions in terms of location, size in millimeters, and ICRS grade. If intraoperative findings differed from preoperative MRI images, measurements and photos taken via arthroscopy were used instead, as direct visualization of lesions was likely to be more accurate. To better define the location of these defects, the femoral condyles were further numbered and defined by a 3 × 3 grid, and the femoral trochlea was divided into thirds (medial, central, and lateral) as per validated ICRS grid map 18. [Figure 1](#fig1){ref-type="fig"} illustrates the grid distribution on the medial femoral condyle (1*A*), lateral femoral condyle (1*B*), and trochlea (1*C*).Figure 1Grid distribution for the medial femoral condyle (A), lateral femoral condyle (B), and femoral trochlea (C). To better characterize the location where articular cartilage defects were occurring, the femoral condyles were divided into 3 × 3 grids, and the femoral trochlea was divided into thirds as per International Cartilage Repair Society (ICRS) grid map 18.

Surgical Technique {#sec1.3}
------------------

All surgical procedures were performed by a sports-trained surgeon on lesions that were ICRS grade III and higher. As previously described by Benthien and Behrens, the surgery began with a routine diagnostic arthroscopy under general anesthesia and tourniquet to confirm preoperative MRI findings and characterize the size and location of the articular cartilage lesion.[@bib11] After the defect was measured and photographed, the lesion was debrided with an arthroscopic shaver until a stable shoulder surrounded the defect. If concurrent injuries, such as meniscal tears, were identified on preoperative MRI scans or intraoperatively, concurrent procedures, such as meniscus repairs or meniscectomies, were performed before proceeding with the microfracture.

Microfracture was performed using either handheld awls or 1.1-mm Kirschner wires drilled at regular 5-mm intervals, as shown in [Figure 2](#fig2){ref-type="fig"}A. Based on measurements made arthroscopically using an arthroscopic probe, a hyaluron-based cell-free scaffold (Hyalofast; Anika Therapeutics, Bedford, MA) was trimmed to match the size of the defect. To facilitate application of the matrix and avoid wetting before contact with the clot, the matrix was inserted with the guidance of makeshift cannula. Such a cannula can be created by removing the plunger of a simple 5-mL plastic syringe and cutting off the tip and distal end of the barrel at an oblique angle, as shown in [Figure 2](#fig2){ref-type="fig"}B. Under dry arthroscopy, the cannula was inserted through the arthroscopic ports and slotted directly over the articular cartilage defect, as shown in [Figure 2](#fig2){ref-type="fig"}C, allowing for AMIC to be performed entirely arthroscopically, after which the matrix is applied through the cannula, thus allowing it to become wet only after contact with the clot.Figure 2All-arthroscopic technique for autologous matrix-induced chondrogenesis. (A) Microfracture of an osteochondral defect in the lateral femoral condyle of the right knee. After debriding away the defect's edges into a stable shoulder, microfracture is performed at 5 mm intervals using an awl or K-wire. (B) Fashioning a cannula to facilitate insertion. Cutting a simple plastic syringe at an oblique angle allows for insertion of the Hyalofast scaffold into the knee without getting the scaffold wet prematurely. (C) Inserting the cannula through an arthroscopic port. Using a standard 5-mL syringe allows for insertion through existing arthroscopic portals due to the small size of the cannula. (D) Application of Hyalofast. The Hyalofast scaffold is directly applied onto the defect and becomes conformable and adherent upon contact with the subchondral blood, thereby facilitating application.

Whereas other authors have advised the use of sutures or resorbable pins to stabilize the matrix, such fixation methods can induce local damage similar to early osteoarthritis and were not used in our study.[@bib12] After the scaffold took on a soft, conformable, adherent texture after coming in contact with blood, the matrix was conformed to the size and shape of the defect using the syringe plunger as a trocar. Multiple scaffold pieces were placed through the cannula if 1 piece of scaffold was insufficient. The scaffold was subsequently allowed to stabilize for ≥15 minutes and was checked for stability in flexion and extension, as shown in [Figure 2](#fig2){ref-type="fig"}D, before wound closure and dressing.

Postoperative Rehabilitation Protocol {#sec1.4}
-------------------------------------

The goal of postoperative rehabilitation is to allow for graduated return to weightbearing without destabilizing the hyaluron-based cell-free scaffold by subjecting it to unnecessary compressive or shearing forces. Therefore, weightbearing and immobilization were dependent on the location of the articular cartilage defect. If a defect was located over a weightbearing surface such as the medial or lateral femoral condyles, patients were advised to immobilize the knee in extension with non-weightbearing for 4 weeks, followed by partial weightbearing with increasing range of motion for 4 weeks, followed by full weightbearing with a full range of activity. If a defect was located over the trochlea or patella, patients were allowed partial weightbearing with the knee locked in extension for 4 weeks, followed by full weightbearing with full range of motion afterward. As in analogous rehabilitation protocols for cartilage repair techniques, patients were allowed to return to low-impact activities only after 6 months and to sports only after 1 year.

Statistical Analysis {#sec1.5}
--------------------

Statistical Package for the Social Sciences (SPSS)® version 24 (IBM Corp., Armonk, NY) was used for all statistical analyses. Results are presented as means with standard deviations and percentages of the total number of knees in the entire patient group. One-way analysis of variance (ANOVA) with a Bonferroni correction was used to compare baseline IKDC scores with those postoperatively to assess for significant differences between scores. Statistical significance was defined as *p* \< .05

Results {#sec2}
=======

Demographic Data {#sec2.1}
----------------

Of 38 patients who underwent the procedure at our institution in the specified time frame, a total of 22 knees in 22 patients fit the inclusion criteria and were analyzed in this study, with a follow-up rate of 57.9%. Basic demographic information including age, sex, ethnicity, height, weight, BMI, and concurrent injuries are detailed in [Table 2](#tbl2){ref-type="table"}. Of the 22 knees analyzed in this study, 19 had concurrent injuries (86.4%), and 11 (50%) underwent a concurrent arthroscopic procedure in the same setting, usually a meniscus repair, debridement, or meniscectomy.Table 2Patient demographicsCharacteristicValueAge (y)47 ± 9.97Sex Male13 (59.1) Female9 (40.9)Height (cm)166.5 ± 8.42Weight (kg)73.34 ± 12.82Body mass index (kg/m^2^)26.45 ± 4.24Ethnicity Chinese14 (63.6) Indian4 (18.2) Malay2 (9.1) Other2 (9.1)Affected knee Left9 (40.9) Right13 (59.1)Concurrent injuries Osteoarthritis13 (59.1) Meniscal tear10 (45.5) MCL/LCL sprain7 (31.8) ACL sprain4 (18.2)[^2]

Characteristics of Articular Cartilage Lesions {#sec2.2}
----------------------------------------------

Descriptive data regarding the articular cartilage lesions are summarized in [Table 3](#tbl3){ref-type="table"}.Table 3Characteristics of articular cartilage lesionsAnatomic LocationFrequencySize (mm)Mean ICRS GradeMedial femoral condyle 1000 238.73 3000 4174 5615.84 62134 7000 8311.74 9000Lateral femoral condyle 1000 2000 3000 4000 548.753 6000 7000 8000 9000Femoral trochlea 11104 24134 3512.24[^3]

Postoperative Outcomes {#sec2.3}
----------------------

Mean IKDC scores preoperatively were 33.5 ± 19.08, 54.58 ± 17.46 at 6 months postoperatively, and 66.19 ± 19.73 at 12 months. Repeated measures ANOVA conducted between preoperative and 6-month postoperative IKDC scores showed a mean difference of 21.1 (95% confidence interval \[CI\] 7.18 to 34.96), which was statistically significant (*p* \< .01). Similarly, a repeated measures ANOVA between 6 months and 2 years postoperatively showed a mean difference of 10.7 (95% CI 3.26 to 26.49), which was statistically significant (*p* \< .01). Mean scores improved by 65.6% at the 6-month mark and 97.6% by the 2-year mark compared with before surgery. No patients were documented to have complications or reoperations during the 2-year follow-up period.

Discussion {#sec3}
==========

The results of this study indicate that patients who underwent microfracture with the Hyalofast scaffold improved their IKDC scores significantly in the short term at 6 months and midterm at 2 years postoperatively. As the minimum clinically important difference for IKDC scores is 11.5, these results suggest that the improvements are both statistically and clinically significant.[@bib19]^,^[@bib20] The overall clinical result of a mean 97% improvement in IKDC scores at the 2-year follow-up suggests comparable or even higher results than what is reported for microfracture alone, which ranges from 70% to 95%.[@bib21], [@bib22], [@bib23] These results suggest that microfracture using a cell-free hyaluron-based scaffold for small articular cartilage lesions may be as effective as, or even more effective than, a single-stage option for patients with articular cartilage defects of the knee. Potential causes for improved postoperative scores compared with microfracture alone include greater mechanical stability, improved defect filling, concentrating effect conferred by the Hyalofast matrix, or all-arthroscopic approach, but further studies with postoperative arthroscopy, imaging, or histological analysis are likely required to confirm such conjecture.

Additionally, the imaging results analyzed in this study indicate that the vast majority of articular cartilage defects occur over the center of the medial femoral condyles. This finding is consistent with the literature, which suggests that the location may correspond with the region of highest pressure on the weightbearing surface.[@bib18]^,^[@bib24]^,^[@bib25] Whereas previous studies have focused on describing cartilage lesions by the Outerbridge, ICRS, or Bauer-Jackson classifications, there is limited existing literature on the specific location of the articular cartilage lesions, and the results of this study provide greater detail on the distribution of articular cartilage lesions in the knee.

Previous studies examining outcomes after microfracture correlated age \>30 years, BMI \>30 kg/m^2^, and longer preoperative duration of symptoms with worse outcomes postoperatively.[@bib21] Furthermore, multiple long-term studies indicate that although short and medium term outcomes are excellent with microfracture, results worsen with time after the 2-year follow-up period, which is thought to be attributed to inferior quality of the regenerated cartilage, making it vulnerable to increased wear.[@bib26], [@bib27], [@bib28] As an early-stage study with limited patients and a 2-year follow-up period, our study was not able to comment on predictors for outcome and longer-term outcomes. Subsequent studies will likely aim to assess over longer periods of follow-up with greater patient numbers to determine how robust postoperative outcomes of all-arthroscopic AMIC using cell-free biological scaffolds are in the long term and whether age, BMI, and preoperative duration of symptoms are similarly correlated with poorer postoperative outcomes.

Future studies should seek to characterize how AMIC using hyaluron-based scaffolds affects cartilage regeneration via microfracture with postoperative arthroscopy, repeat imaging, or histological studies. It may also be useful to characterize the specific biomechanical properties of the clot formed using the hyaluron-based scaffold in comparison to a standard microfracture procedure. Comparing AMIC with other established treatments for articular cartilage lesions, such as osteochondral grafting or osteochondral transfer systems, in terms of clinical outcome, cost, and patient satisfaction will be useful in defining treatment algorithms. Additionally, it may be useful to compare the outcomes from an all-arthroscopic approach to AMIC with those requiring a mini-arthrotomy or larger incision, particularly with regard to wound-related complications and postoperative outcomes. Lastly, because articular cartilage lesions of the knee predispose to early osteoarthritis, long-term clinical outcomes data would be useful in assessing AMIC's long-term efficacy.

Limitations {#sec3.1}
-----------

The main limitations of the current study were the retrospective evaluation of prospectively collected data, as well as the limited number of patients recruited into the study. Because of patients lost to follow-up or excluded owing to incomplete data, only 57.9% of patients who underwent the procedure were included for analysis, and only 1 outcome metric, the IKDC score, was used in evaluating patients. Preoperative duration of symptoms was not documented. In view of cost to patients, performing postoperative MRI scans and arthroscopy were not routinely performed and could not be used to assess for cartilage healing. As the study was designed as a preliminary analysis of a new technique for the AMIC procedure, the power of the study was not calculated and may not be adequate due to limited number of patients.

Conclusion {#sec3.2}
----------

An all-arthroscopic technique for single-stage autologous matrix-induced chondrogenesis demonstrates significant early clinical improvement for the treatment of articular cartilage lesions of the knee.
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[^1]: The study's inclusion and exclusion criteria were designed to select for patients with symptomatic articular cartilage lesions \<20 mm in diameter treated with AMIC using a cell-free hyaluron-based scaffold with both a preoperative MRI and adequate postoperative follow-up. Abbreviations: AMIC, autologous matrix-induced chondrogenesis; ICRS, International Cartilage Repair Society.

[^2]: Data are mean ± standard deviation or n (%). Abbreviations: ACL, anterior cruciate ligament; LCL, lateral collateral ligament; MCL, medial collateral ligament.

[^3]: Based on preoperative imaging and intra-operative findings, articular cartilage lesions are described according to their location, size, and mean International Cartilage Repair Society (ICRS) grade. Specific locations of the lesions are detailed in [Figure 1](#fig1){ref-type="fig"}A--C.
